FIELD: medicine, virology. SUBSTANCE: vaccine - tablets coated with protective acid-resistant shell that consist of recombinant smallpox virus expressing preS2-Ag and HBs-Ag and vehicle (lactose, sucrose, vanillin, calcium stearate). Use of this preparation ensures to increase safety and effectiveness of hepatitis B and smallpox specific prophylaxis. EFFECT: enhanced effectiveness of vaccine. 2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING | 2002 |
|
RU2242246C2 |
KIT OF TABLETTED ALIVE RECOMBINANT ORAL BIVACCINE AGAINST SMALLPOX AND HEPATITIS B AND METHOD FOR VACCINATION AT APPLYING THE KIT MENTIONED | 2005 |
|
RU2302259C2 |
LIVE RECOMBINANT VACCINE FOR PROPHYLACTIC OF HEPATITIS B AND SMALLPOX FOR EPICUTANEOUS APPLICATION AND METHOD FOR ITS PRODUCTION | 1992 |
|
RU2073524C1 |
METHOD FOR PRODUCTION OF PELLETIZED EMBRYONIC VARIOLAR LIVING VACCINE | 2005 |
|
RU2290949C1 |
PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS B PROPHYLAXIS | 1998 |
|
RU2135209C1 |
AGENT FOR ARRESTING UNDESIRABLE VACCINAL REACTIONS AND COMPLICATIONS DURING PRIMARY VACCINATION WITH VARIOLAR VACCINES AND METHOD FOR USE THEREOF | 2013 |
|
RU2542490C1 |
INACTIVATED FETAL DRY TABLETED SMALLPOX VACCINE FOR ORAL ADMINISTRATION OF “THAOVIN” AND A METHOD FOR ITS PREPARATION | 2016 |
|
RU2651040C2 |
RECOMBINANT PLASMID DNA PTBI-HBSAG COMPRISING CHIMERIC GENE TBI-HBSAG UNDER CONTROL OF SMALLPOX VACCINE PROMOTER P7,5K AND STRAIN OF RECOMBINANT SMALLPOX VACCINE INDUCING IMMUNE RESPONSE AGAINST HIV AND HUMAN HEPATITIS B IN ANIMAL BODY | 2001 |
|
RU2194075C2 |
POLYEPITOPIC ANTI-HEPATITIS B VACCINE OF 4-TH GENERATION AND METHOD OF OBTAINING IT | 2011 |
|
RU2469741C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1996 |
|
RU2123331C1 |
Authors
Dates
1997-04-10—Published
1994-03-23—Filed